- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Significant Ownership of Rosalind Advisors, Inc.
- Signature - Title
- Steven Salamon - President
- Location
- Toronto
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Rosalind Advisors, Inc..
Follow Filing Activity
Follow Rosalind Advisors, Inc. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Rosalind Advisors, Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYSTEMS, INC. | DELCATH SYSTEMS, INC. | 9.9% | $70,022,327 | +$468,900 | 6,719,993 | +0.67% | Rosalind Advisors, Inc. | 31 Dec 2025 |
| PYPD | PolyPid Ltd. | Common Shares | 9.9% | $25,443,176 | -$1,030,600 | 5,483,443 | -3.9% | Rosalind Advisors, Inc. | 31 Dec 2025 |
| TLPH | TALPHERA, INC. | Common Shares | 9.9% | $13,545,483 | -$830,679 | 13,150,954 | -5.8% | Rosalind Advisors, Inc. | 31 Dec 2025 |
| BFRI | Biofrontera Inc. | Common Shares | 9.9% | $11,817,810 | -$429,412 | 16,188,781 | -3.5% | Rosalind Advisors, Inc. | 31 Dec 2025 |
| MYO | MYOMO, INC. | Common Shares | 9.9% | $7,527,000 | +$48,494 | 7,603,030 | +0.65% | Rosalind Advisors, Inc. | 31 Dec 2025 |
| KPRX | KIORA PHARMACEUTICALS INC | Common Shares | 9.9% | 464,676 | 0% | Rosalind Advisors, Inc. | 31 Dec 2025 | ||
| FENC | FENNEC PHARMACEUTICALS INC. | Common Shares | 9.8% | $21,095,731 | +$5,145,600 | 2,746,840 | +32% | Rosalind Advisors, Inc. | 31 Dec 2025 |
| NSPR | InspireMD, Inc. | Common Shares | 9.2% | $19,557,045 | 10,987,104 | 0% | Rosalind Advisors, Inc. | 31 Dec 2025 | |
| MDWD | MediWound Ltd. | Common Shares | 7% | 912,319 | 0% | Rosalind Advisors, Inc. | 31 Dec 2025 | ||
| CLRB | Cellectar Biosciences, Inc. | Common Shares | 5.5% | 247,715 | -97% | Rosalind Advisors, Inc. | 31 Dec 2025 | ||
| TRVI | Trevi Therapeutics, Inc. | Common Shares | 1.2% | $6,746,875 | 1,062,500 | Rosalind Advisors, Inc. | 13 Feb 2025 | ||
| OPTN | OptiNose, Inc. | Common Shares | 0% | $0 | -$3,128,407 | 0 | -100% | Rosalind Advisors, Inc. | 30 Jun 2025 |
| SPRB | SPRUCE BIOSCIENCES, INC. | Common shares | 0% | $0 | 0 | Rosalind Advisors, Inc. | 31 Dec 2024 |
Schedules 13D/G Reported by Rosalind Advisors, Inc.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.